Proteogenomics and transcriptomics have identified ferroptosis-related gene networks (e.g., GPX4, SLC7A11, ACSL4) as predictors of immunotherapy responsiveness, while single-cell RNA sequencing has revealed heterogeneity in ferroptosis sensitivity across tumor and immune subsets. Here, GPX4 is linked to neoplasm.